Morgan Stanley
OBCI

Morgan Stanley’s Ocean Bio-Chem Inc OBCI Stock Holding History

Morgan Stanley’s Portfolio OBCI Stock Details OBCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-82
Closed -$1K – 8231
2022
Q1 		$1K Buy
82
+81
+8,100% +$725 ﹤0.01% 7925
2021
Q4 		$0 Buy
+1
New +$10 ﹤0.01% 8310
2021
Q1 		– Sell
-57
Closed -$1K – 7626
2020
Q4 		$1K Buy
+57
New +$817 ﹤0.01% 7001
2020
Q3 		– Sell
-100
Closed -$1K – 6900
2020
Q2 		$1K Buy
+100
New +$667 ﹤0.01% 6555
2018
Q3 		– Sell
-636
Closed -$2K – 6865
2018
Q2 		$2K Buy
+636
New +$2.25K ﹤0.01% 6570
2017
Q4 		– Sell
-370
Closed -$2K – 6707
2017
Q3 		$2K Sell
370
-436
-54% -$1.87K ﹤0.01% 6413
2017
Q2 		$4K Sell
806
-548
-40% -$2.43K ﹤0.01% 6391
2017
Q1 		$7K Sell
1,354
-1,573
-54% -$6.68K ﹤0.01% 6305
2016
Q4 		$11K Buy
+2,927
New +$9.68K ﹤0.01% 6140
2016
Q2 		– Sell
-13
Closed – – 6721
2016
Q1 		$0 Sell
13
-3
-19% -$7 ﹤0.01% 6788
2015
Q4 		$0 Buy
+16
New +$40 ﹤0.01% 6858
2015
Q3 		– Sell
-16
Closed – – 6777
2015
Q2 		$0 Buy
+16
New +$61 ﹤0.01% 6799
2015
Q1 		– Sell
-15
Closed – – 6704
2014
Q4 		$0 Sell
15
-68
-82% -$263 ﹤0.01% 6714
2014
Q3 		$0 Sell
83
-246
-75% -$765 ﹤0.01% 6702
2014
Q2 		$1K Buy
329
+314
+2,093% +$913 ﹤0.01% 6453
2014
Q1 		$0 Buy
+15
New +$44 ﹤0.01% 6582

Other funds holding OBCI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Morgan Stanley's OBCI Position: Q2 2022 in Review

Morgan Stanley sold out of Ocean Bio-Chem Inc (OBCI) in Q2 2022, closing a stake of 82 shares — an estimated $1K sold.

Morgan Stanley first reported a position in OBCI in Q1 2014 and held it in 16 quarters. The position peaked at $11K in Q4 2016. 17 funds tracked by Wall St. Rank hold OBCI as of Q2 2022.

  • Morgan Stanley reported no remaining Ocean Bio-Chem Inc position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 82 Ocean Bio-Chem Inc shares in Q2 2022, an estimated $1K.
  • Morgan Stanley first reported a position in Ocean Bio-Chem Inc in Q1 2014 and held it in 16 quarters.
  • Morgan Stanley's Ocean Bio-Chem Inc position peaked at $11K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.